PHILADELPHIA, April 07, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics Inc. (NASDAQ: AXSM) Class Actio...
Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) - William Blair decreased their Q1 2025 earnin...
HC Wainwright reaffirmed a "buy" rating and set a $200.00 price objective on shares of Axsome Therap...
Vanguard Group Inc. trimmed its holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by...
PHILADELPHIA, April 04, 2025 (GLOBE NEWSWIRE) -- Arqit Quantum Inc. (NASDAQ: ARQQ) Class Action Surv...